Pay in 4 interest-free payments of $5.16 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Patients with established cardiovascular disease and overweight or obesity
You consent to automatic charges unless you explicitly request cancellation before your next payment processes
Gallbladder problems : In rare cases, tirzepatide may increase the risk of gallstones or gallbladder inflammation
Study: Triple-Hormone-Receptor Agonist Retatrutide for Obesity Journal: New England Journal of Medicine (NEJM) ClinicalTrials ID: NCT04881760 View Full Study Retatrutide is a glucagon, GLP-1, and GIP (triple hormone) receptor agonist being investigated to treat obesity
However, it is vital to remember that these results are not a diagnosis
US$ 20.86
US$ 25.79
US$ 25.40
US$ 28.43
US$ 25.56
US$ 27.17
US$ 24.50
US$ 27.42
US$ 22.39
